Neuro-Oncology Reviews
Volume
27 Number 31
10 November 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 31, 10 November
Hoberstorfer T, Ay C, Riedl J.
Mechanisms
and treatment of venous thromboembolism in patients with brain
cancer: A narrative review.
J
Thromb Haemost. 2025 Nov 2:S1538-7836(25)00722-6. doi:
10.1016/j.jtha.2025.10.022. PMID:
41187830. Review. ˍ
Cai Y, Huang S, Dong Y, Li S, Jin X.
PIWI-Interacting
RNAs in brain health and disease: biogenesis, mechanisms, and
therapeutic horizons.
Psychopharmacology
(Berl). 2025 Nov 3. doi:
10.1007/s00213-025-06958-w. PMID:
41182353. Review˰
ˍ
Chuck C, Teshome A, Lin A, Sayeed S, Wang E, Amaral-Nieves N,
Taman M, Oldam J, Chen HC, Desai B, Kopecky A, Rivard MJ, Sarangi
S, Elinzano H, Wong ET, Ciarelli CP, Chen CC.
Redefining
the therapeutic landscape of glioblastomas and brain metastasis
through cesium brachytherapy and low-kV intra-operative radiation
therapy (IORT).
J
Neurooncol. 2025 Nov 3;176(1):66. doi:
10.1007/s11060-025-05262-z. PMID:
41182498. Review˰
ˍ
Gulsuna B, Lopez R, Kemp RDW, Yurtluk MD, Erkan B, Özaydin B,
McNall-Knapp RY, Balsara K.
The
current status of immune checkpoint inhibitors in pediatric CNS
tumors: a systematic review with a representative case of
CMMRD-associated glioma.
J
Neurooncol. 2025 Nov 3;176(1):63. doi:
10.1007/s11060-025-05241-4. PMID:
41182427. Review;
Case report˰
ˍ
Królikowska A, Tarnowski M.
CAR-T
cells immunotherapy in the treatment of glioblastoma.
Cancer
Immunol Immunother. 2025 Nov 6;74(12):363. doi:
10.1007/s00262-025-04222-w. PMID:
41196398. Review. ˍ
Söderberg-Naucler C, Pantalone MR, Stragliotto G, Bartek J.
Does human cytomegalovirus provide a
novel therapeutic target for patients with glioblastoma?
Philos
Trans R Soc Lond B Biol Sci. 2025 Nov
6;380(1938):20240403. doi:
10.1098/rstb.2024.0403. PMID:
41194660. Review. ˍ
Soffietti R.
Neuro-oncology is moving
quickly toward new horizons of diagnosis and treatment.
Curr
Opin Neurol. 2025 Nov 6;38(6):678-680. doi:
10.1097/WCO.0000000000001429. PMID:
41189510. Editorial˰
ˍ
Adeyemo TA, Greenley S, Ware F, Haque F, Maraveyas A, Jones WS.
Evidence gap in predicting
intracranial haemorrhage risk in people with glioma on
anticoagulants: a scoping review.
BMC
Neurol. 2025 Nov 7;25(1):458. doi:
10.1186/s12883-025-04461-5. PMID:
41204188. Review. ˍ
Peters KB.
New and Emerging Therapies
for Patients with Low-Grade Glioma.
CNS
Drugs. 2025 Nov 7. doi:
10.1007/s40263-025-01238-9. PMID:
41201564. Review˰
ˍ
Chavaz L, Bagchi A, Dhanda SK, Toutain F, Pfister SM, Sturm D,
Pietsch T, Gielen GH, Waha A, Clarke M, Lu C, Karremann M, Benesch
M, Perwein T, Nussbaumer G, Kramm C, Massimino M, Biassoni V,
Vinci M, Mastronuzzi A, van Vuurden D, Veldhuijzen van Zanten SEM,
Mackay A, Jones C, Jones DTW, Guerreiro Stucklin AS, Tabori U,
Hawkins C, Ryall S, Morales La Madrid A, Lassaletta A, Bailey S,
Hargrave D, Chiang J, El-Ayadi M, Mançano BM, Manuel Reis
R, Hagel C, Gorsi H, Silvestrini N, Gilani A, Papusha L, Klimo P
Jr, Zhou X, Gajjar A, Robinson GW, von Bueren AO.
A
Systematic Study of Molecular Diagnosis, Treatment and Prognosis
in Infant-Type Hemispheric Glioma): An Individual Patient Data
Meta-analysis of 164 patients.
Neuro
Oncol. 2025 Nov 8:noaf264. doi:
10.1093/neuonc/noaf264. PMID:
41206756. Meta-analysis. ˍ
Li W, Guo R, Zhang R, Wang Y, Cao R, Liu Y, Chen R, Wu G, Wang D.
Mapping the landscape: a comprehensive
bibliometric analysis of immunotherapy advances in glioblastoma
research.
Discov
Oncol. 2025 Nov 10;16(1):2067. doi:
10.1007/s12672-025-03776-6. PMID:
41212389. Bibliometric analysis. ˍ